StockMarketWire.com - Peel Hunt today reaffirms its hold investment rating on Hikma Pharmaceuticals PLC [LON:HIK] and cut its price target to 1870p (from 2000p).

Story provided by StockMarketWire.com

Broker Forecasts data provided by www.sharesmagazine.co.uk